- Abstract Number: 33
B Cell Abnormalities in Patients with Chronic Cutaneous Lupus Erythematosus
- Abstract Number: 2974
B Cell Binding Autoreactive VH4.34 Antibodies Are Specific to Lupus, Consist of Diverse Isotypes, and Are Associated with High Disease Activity and Lupus Nephritis
- Abstract Number: 836
B Cell Receptor Sequencing of Anti-Citrullinated Protein Antibody Expressing B Cells Indicates a Selective Advantage for the Introduction of N-Glycosylation Sites during Somatic Hypermutation
- Abstract Number: 898
B Cell Specific TLR9 Suppresses Disease in Murine Lupus
- Abstract Number: 807
B Cells in Giant Cell Arteritis: a Novel Target for Treatment?
- Abstract Number: 40
B-Cell Attracting Chemokine-1 (BCA-1) and Macrophage Inflammatory Protein-3 Alpha (MIP-3α) Act Synergistically in the Recruitment of B Cells in the Rheumatoid Synovium
- Abstract Number: 2936
B-Cell Depletion By Rituximab Affects the Distribution of Effector Th-Cell Subsets in Patients with ANCA Associated Vasculitis
- Abstract Number: 35
B-Cell Subset Differences in Inflammatory Rheumatic Diseases
- Abstract Number: 56
Baicalein, a Plant-Derived Small Molecule, Activate Nrf2/Autophagy Signaling Axis Via MEK1/2-ERK1/2-Elk1 Pathway to Suppress the Expression of IL-6 in Human Osteoarthritis Chondrocytes
- Abstract Number: 415
Baricitinib Reduces GlycA Levels in Phase 2 and Phase 3 Clinical Trials in Patients with Moderate to Severe Rheumatoid Arthritis
- Abstract Number: 2316
Barriers at School for Children with Juvenile Idiopathic Arthritis (JIA) – a Patient Reported Outcome
- Abstract Number: 225
Barriers to the Use of Methotrexate in Ethiopia: Survey of Pharmacy Providers
- Abstract Number: 2002
Baseline 18F Sodium Fluoride Uptake of Vertebral Bodies but Not Vertebral Corners on Positron Emission Tomography Is Associated with Changes in Bone Mineral Density at Lumbar Vertebrae in Ankylosing Spondylitis: A 1-Year Longitudinal Study
- Abstract Number: 436
Baseline Anemia As a Predictor of Radiographic Progression in Tofacitinib-Treated Rheumatoid Arthritis Patients: Post Hoc Analyses from Two Phase 3 Trials
- Abstract Number: 1695
Baseline Characteristics and Outcomes in a Retrospective Cohort of Patients with Systemic Sclerosis Related Interstitial Lung Disease
- Abstract Number: 134
Baseline Characteristics and Rates of Hospitalized Infections in Patients with Rheumatoid Arthritis Treated with Non-TNF Inhibitors in Denmark and Sweden
- Abstract Number: 2593
Baseline Characteristics of Patients Diagnosed with Systemic Lupus Erythematosus Initiating Treatment with Intravenous Belimumab
- Abstract Number: 2526
Baseline Data from the Recent-Onset Psoriatic Arthritis Registry of the Spanish Society of Rheumatology
- Abstract Number: 2434
Baseline Expressions of Cellular microRNA-31 and microRNA-10a Predict Remission and Low Disease Activity in Patients with Early Rheumatoid Arthritis after Six and Twelve Months of Therapy
- Abstract Number: 672
Baseline Hyperuricemia As a Predictive Value for Development of Lupus Nephritis in Premenopausal SLE Patients
- Abstract Number: 2201
Baseline Periarticular Tibial Knee Bone Mineral Density Is Associated with Change in Static Alignment
- Abstract Number: 610
Baseline Structural Damage Predicts Response to Abatacept in Patients with Psoriatic Arthritis: A Post Hoc Analysis from a Phase III Study
- Abstract Number: 868
Baseline Troponin Levels Are Associated with Mortality in a Cohort of Patients with Inflammatory Polyarthritis: Results from the Norfolk Arthritis Register
- Abstract Number: 412
Baseline Values for Plantar Pressure and Background Characteristics As Indicators for the Limit of Conservative Treatment of Rheumatoid Forefoot Deformity
- Abstract Number: 465
Basement Membrane Remodeling in Rheumatoid Arthritis Associates with Disease Activity, Response to IL-6 Inhibitor Treatment and Radiographic Progression: Analysis of Two Phase III Clinical Trials
- Abstract Number: 2720
Behcet’s Disease in Southeastern Michigan: A Single Center Comparative Study
- Abstract Number: 540
Being Elderly Is Not a Predictive Factor of Discontinuation of Abatacept Due to Adverse Events in Rheumatoid Arthritis Patients with Concomitant Methotrexate: A Retrospective Observational Study Based on Data from a Japanese Multicenter Registry Study
- Abstract Number: 1400
Beneficial Effect of Anti-IL-6 Blockade on Insulin Resistance and Insulin Sensitivity in Patients with Rheumatoid Arthritis
- Abstract Number: 1796
Benefits and Sustainability of a Learning Collaborative for Implementation of Treat to Target in Rheumatoid Arthritis: Results of Phase II of a Cluster Randomized Controlled Trial
- Abstract Number: 45
BIIB063, a Potent Anti-CD40 Antagonistic Monoclonal Antibody (MAb): Lessons Learned from an Early Development Program.
- Abstract Number: 299
Bik Plays an Important Role of Cell Proliferation Caused By Nitric Oxide in Rheumatoid Arthritis Synovium
- Abstract Number: 2397
Bilateral Femoral DXA Scan in Patients with Rheumatoid Arthritis
- Abstract Number: 1936
Bimekizumab Blocks T Cell-Mediated Osteogenic Differentiation of Periosteal Stem Cells: Coupling Pathological Bone Formation to IL-17A and IL-17F Signaling
- Abstract Number: 1571
Bimekizumab Dual Inhibition of IL-17A and IL-17F Provides Evidence of IL-17F Contribution to Chronic Inflammation in Disease-Relevant Cells
- Abstract Number: 307
Biochemical Intervertebral Disc Alterations in Patients with Low Back Pain and Radiculopathy
- Abstract Number: 922
Biologic DMARD Prescribing Patterns in Elderly Patients with Rheumatoid Arthritis
- Abstract Number: 2278
Biologic Switching Among JIA Patients: A Cohort Study in the Childhood Arthritis and Rheumatology Research Alliance Registry
- Abstract Number: 1046
Biological and Targeted Synthetic Dmards’ Prior Authorization Time Is Significantly Reduced with Pharmacy Presence in the Rheumatology Clinic
- Abstract Number: 1562
Biological DMARD Efficacy in Psoriatic Arthritis: A Systematic Review and Meta-Analysis on ACR Response Criteria, PASI Response Criteria, HAQ-DI, Enthesitis and Dactylitis Outcomes
- Abstract Number: 2405
Biological Function Integrated Prediction of Severe Radiographic Progression in Rheumatoid Arthritis: A Nested Case Control Study
- Abstract Number: 2332
Biomarkers for the Diagnosis and the Identification of Risk of Macrophage Activation Syndrome (MAS) in Systemic Juvenile Idiopathic Arthritis (sJIA)
- Abstract Number: 1211
Biomarkers Predictive of Pain Improvement in Knee Osteoarthritis Subjects Treated with the Anti-IL-1α/β Dual Variable Domain Immunoglobulin ABT-981
- Abstract Number: 572
Biopsy Accuracy in Sjögren’s Syndrome: Analysis of 803 Patients Presenting with Sicca Syndrome Referred to Labial Salivary Gland Biopsy
- Abstract Number: 226
Biopsy Proven Giant Cell Arteritis in African Descent Populations: Incidence and Characteristics in Martinique, French West Indies
- Abstract Number: 2442
Biosimilar Candidate BI 695501 and Adalimumab Reference Product Have Similar Efficacy and Safety in Patients with Moderately-to-Severely Active Rheumatoid Arthritis (RA): 1-Year Results from a Phase III Study
- Abstract Number: 1037
Biosimilar Knowledge Among US Rheumatologists – a Survey
- Abstract Number: 2287
Biosimilar Use in Children and Young People with Juvenile Idiopathic Arthritis in a Real-World Setting in the United Kingdom
- Abstract Number: 2495
Biosimilarity between Humira® and the Biosimilar Candidate SB5 in Product Quality
- Abstract Number: 1036
Blood Glucose Changes Surrounding Initiation of Tumor-Necrosis Factor Inhibitors and Conventional Disease-Modifying Anti-Rheumatic Drugs in Veterans with Rheumatoid Arthritis
- Abstract Number: 2110
Blood Group ”a“ Was Increased in FMF Patients and Blood Group ”0“ May be Associated with Colchicine Resistance
- Abstract Number: 1918
Blood Levels of Complement Split Product iC3b and C3 Outperform Traditional Biochemical Measures of SLE Disease Activity in Associating with Active and Clinically Meaningful Changes
- Abstract Number: 1267
Blood Pressure Control over Time in Childhood-Onset Systemic Lupus Erythematous
- Abstract Number: 503
BMS-986195 Is a Highly Selective and Rapidly Acting Covalent Inhibitor of Bruton’s Tyrosine Kinase with Robust Efficacy at Low Doses in Preclinical Models of RA and Lupus Nephritis
- Abstract Number: 514
BMS-986195, a Novel, Rapidly Acting, Covalent Inhibitor of Bruton’s Tyrosine Kinase: Safety, Pharmacokinetic and Pharmacodynamic Profiles in Healthy Participants
- Abstract Number: 2961
Body Composition and Myokine Levels in Juvenile Dermatomyositis and Associations with Physical Function
- Abstract Number: 1634
Body Mass Index and Disease Activity in Systemic Lupus Erythematosus- a Paradoxical Relationship?
- Abstract Number: 2378
Body Mass Index and Persistence of Conventional Dmards and TNF Inhibitors in Rheumatoid Arthritis
- Abstract Number: 1636
Body Mass Index at Disease Onset Is Predictive of Future Organ Damage in Systemic Lupus Erythematosus
- Abstract Number: 1472
Body Mass Index Does Not Affect Response to Rituximab in Patients with Rheumatoid Arthritis: Results from Turkbio Registry
- Abstract Number: 609
Body Mass Index Does Not Influence the Efficacy of Subcutaneous Abatacept in Patients with Psa: Results from a Phase III Trial
- Abstract Number: 1830
Bone Marrow Edema in Sacroiliac Joints of Young Athletes Is Common and Shows Most Frequently in the Posterior Lower Ilium
- Abstract Number: 1224
BONE Metabolism in LIVER Transplant Patients Two-Year Study. Influence of Medical Intervention PRIOR to Surgery and Antiresorptive Treatment
- Abstract Number: 1225
BONE Mineral Density and Vertebral Fractures in Gaucher Disease Patients Treated with Imiglucerase
- Abstract Number: 22
Bone Regulatory Cytokine Production By B Cells in Rheumatoid Arthritis Is Dependent on NF-κb Activation and Autophagy Pathways
- Abstract Number: 1183
Bone Sarcoidosis: A Multicenter Study
- Abstract Number: 1594
Bone Turnover Markers in Adults with Systemic Lupus Erythematosus
- Abstract Number: 2671
Bosentan in Scleroderma Renal Crisis: A National Open Label Prospective Study
- Abstract Number: 2319
Bradycardia after High-Dose Solu-Medrol
- Abstract Number: 2753
Brain Functional Connectivity Features of Pain Centralisation Relate to Degree of ‘Fibromyalgianess’ in Rheumatoid Arthritis
- Abstract Number: 1735
Brain Infiltrating CD4 T Cells Have a Pathogenic T Follicular Helper-like Phenotype in Neuropsychiatric Lupus
- Abstract Number: 1912
Broad Immunophenotyping Results: CCR10 Expressing CD8 T Cells Distinguish Psoriatic Arthritis from Psoriasis Limited to Skin Involvement
- Abstract Number: 29
BTK Inhibition Ameliorates Lupus-Associated Neuropsychiatric and Skin Disease
- Abstract Number: 2561
BTK Inhibition Ameliorates Renal Disease in Spontaneous Murine Lupus Nephritis
- Abstract Number: 1057
Budgetary Impact Analysis of Real-World Dosing Patterns in Matched Cohorts of Rheumatoid Arthritis Patients Treated with Infliximab or Golimumab Intravenous Anti-TNF Medications
- Abstract Number: 3
Burden of Antiphospholipid Syndrome in a Thromboembolic Disease Registry
- Abstract Number: 1033
Burden of Illness in Patients with RA and Anti-Cyclic Citrullinated Peptide Positivity
- Abstract Number: 1958
Burden of Rheumatic Disease Among Korean Women in Childbearing Years Based on the National Health Insurance Service-National Sample Cohort
2017 ACR/ARHP Annual Meeting
November 3-8, 2017. San Diego, CA.